Seven Novel Variants of Weiss-Kruszka Syndrome and Phenotype Expansion.

ZNF472 GestaltMatcher Weiss‐Kruszka syndrome phenotypic heterogeneity

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
17 Sep 2024
Historique:
revised: 09 08 2024
received: 06 06 2024
accepted: 10 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 17 9 2024
Statut: aheadofprint

Résumé

Weiss-Kruszka syndrome (WKS) is a rare genetic disorder characterized by metopic ridging, ptosis, arched eyebrows, down slanting palpebral fissures, abnormalities in the corpus callosum, cardiac malformations, and variable neurodevelopmental delay. To date, 32 individuals with a diagnosis of WKS have been reported in the literature. The syndrome is caused by a heterozygous pathogenic variant in the ZNF462 gene or a deletion of the 9p31.2 region involving ZNF462. There is significant phenotypic heterogeneity and intrafamilial variability among these patients. Our study reviewed nine patients from seven unrelated families and identified seven novel heterozygous ZNF462 variants through exome sequencing. GestaltMatcher analysis of our cohort's facial images, alongside previously published images of ZNF462 patients, demonstrated a high degree of facial similarity. Further longitudinal research is needed to delineate this rare condition's long-term health implications and adult-onset features.

Identifiants

pubmed: 39287049
doi: 10.1002/ajmg.a.63856
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e63856

Informations de copyright

© 2024 The Author(s). American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Brady, L., M. Ballantyne, J. Duck, et al. 2023. “Further Characterization of the 9q31 Microdeletion Phenotype; Delineation of a Common Region of Overlap Containing ZNF462.” Molecular Genetics & Genomic Medicine 11, no. 3: e2116. https://doi.org/10.1002/mgg3.2116.
Chang, Y. S., A. Stoykova, K. Chowdhury, and P. Gruss. 2007. “Graded Expression of Zfp462 in the Embryonic Mouse Cerebral Cortex.” Gene Expression Patterns 7, no. 4: 405–412. https://doi.org/10.1016/J.MODGEP.2006.11.009.
Constantinou, M., M. Lampi, K. Parperis, et al. 2023. “A Novel Pathogenic Variant in ZNF462 Gene Associated With Weiss–Kruszka Syndrome and Systemic Lupus Erythematosus.” Rheumatology 7, no. 4: 405–412. https://doi.org/10.1093/rheumatology/kead035.
Cosemans, N., L. Vandenhove, J. Maljaars, et al. 2018. “ZNF462 and KLF12 are Disrupted by a De Novo Translocation in a Patient With Syndromic Intellectual Disability and Autism Spectrum Disorder.” European Journal of Medical Genetics 61, no. 7: 376–383. https://doi.org/10.1016/j.ejmg.2018.02.002.
Eberl, H. C., C. G. Spruijt, C. D. Kelstrup, M. Vermeulen, and M. Mann. 2013. “A Map of General and Specialized Chromatin Readers in Mouse Tissues Generated by Label‐Free Interaction Proteomics.” Molecular Cell 49, no. 2: 368–378. https://doi.org/10.1016/j.molcel.2012.10.026.
González‐Tarancón, R., E. Salvador‐Rupérez, M. D. Miramar Gallart, et al. 2022. “A Novel Mutation in the ZNF462 Gene c.3306dup; p.(Gln1103Thrfs*10) is Associated to Weiss‐Kruszka Syndrome. A Case Report.” Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine 77, no. 1: 118–121. https://doi.org/10.1080/17843286.2020.1780391.
Hsieh, T. C., A. Bar‐Haim, S. Moosa, et al. 2022. “GestaltMatcher Facilitates Rare Disease Matching Using Facial Phenotype Descriptors.” Nature Genetics 54, no. 3: 349–357. https://doi.org/10.1038/s41588‐021‐01010‐x.
Hustinx, A., F. Hellmann, O. Sümer, et al. 2023. “Improving Deep Facial Phenotyping for Ultra‐Rare Disorder Verification Using Model Ensembles.” https://db.gestaltmatcher.org/.
Iivonen, A. P., J. Kärkinen, V. Yellapragada, et al. 2021. “Kallmann Syndrome in a Patient With Weiss‐Kruszka Syndrome and a De Novo Deletion in 9q31.2.” European Journal of Endocrinology 185, no. 1: 57–66. https://doi.org/10.1530/EJE‐20‐1387.
Kruszka, P. 1993. “Weiss‐Kruszka Syndrome.” In GeneReviews® [Internet], edited by M. P. Adam, J. Feldman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. Bean, K. W. Gripp, and A. Amemiya. Seattle, WA: University of Washington. https://www.ncbi.nlm.nih.gov/books/NBK549204/.
Kruszka, P., T. Hu, S. Hong, et al. 2019. “Phenotype Delineation of ZNF462 Related Syndrome.” American Journal of Medical Genetics, Part A 179, no. 10: 2075–2082. https://doi.org/10.1002/ajmg.a.61306.
Laurent, A., J. Masse, F. Omilli, et al. 2009. “ZFPIP/Zfp462 is Maternally Required for Proper Early Xenopus Laevis Development.” Developmental Biology 327, no. 1: 169–176. https://doi.org/10.1016/j.ydbio.2008.12.005.
Lesmann, H., G. J. Lyon, P. Caro, et al. 2023. “GestaltMatcher Database—A FAIR Database for Medical Imaging Data of Rare Disorders.” medRxiv: The Preprint Server for Health Sciences. Published ahead of print, June 10, 2023. https://doi.org/10.1101/2023.06.06.23290887.
Massé, J., A. Laurent, B. Nicol, D. Guerrier, I. Pellerin, and S. Deschamps. 2010. “Involvement of ZFPIP/Zfp462 in Chromatin Integrity and Survival of P19 Pluripotent Cells.” Experimental Cell Research 316, no. 7: 1190–1201. https://doi.org/10.1016/J.YEXCR.2010.02.024.
Park, J., D. J. Ha, G. H. Seo, et al. 2021. “Empty Sella Syndrome Associated With Growth Hormone Deficiency: The First Case Report of Weiss‐Kruszka Syndrome.” Journal of Korean Medical Science 36, no. 18: 1–8. https://doi.org/10.3346/jkms.2021.36.e133.
Pellino, G., L. Chiasso, G. Fiori, et al. 2022. “Acute Lymphoblastic Leukemia in a Child With Weiss‐Kruszka Syndrome: Casual or Causal Association?.” European Journal of Medical Genetics 65, no. 4: 104457. https://doi.org/10.1016/j.ejmg.2022.104457.
Ramocki, M. B., J. Dowling, I. Grinberg, et al. 2003. “Reciprocal Fusion Transcripts of Two Novel Zn‐Finger Genes in a Female With Absence of the Corpus Callosum, Ocular Colobomas and a Balanced Translocation Between Chromosomes 2p24 and 9q32.” European Journal of Human Genetics 11, no. 7: 527–534. https://doi.org/10.1038/sj.ejhg.5200995.
Richards, S., N. Aziz, S. Bale, et al. 2015. “Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.” Genetics in Medicine 17, no. 5: 405–424. https://doi.org/10.1038/gim.2015.30.
Talisetti, A., S. R. Forrester, D. Gregory, L. Johnson, M. C. Schneider, and V. E. Kimonis. 2003. “Temtamy‐Like Syndrome Associated With Translocation of 2p24 and 9q32.” Clinical Dysmorphology 12, no. 3: 175–177. https://doi.org/10.1097/01.mcd.0000072161.33788.56.
Wang, B., Y. Zheng, H. Shi, et al. 2017. “Zfp462 Deficiency Causes Anxiety‐Like Behaviors With Excessive Self‐Grooming in Mice.” Genes, Brain and Behavior 16, no. 2: 296–307. https://doi.org/10.1111/gbb.12339.
Weiss, K., K. Wigby, M. Fannemel, et al. 2017. “Haploinsufficiency of ZNF462 Is Associated With Craniofacial Anomalies, Corpus Callosum Dysgenesis, Ptosis, and Developmental Delay.” European Journal of Human Genetics 25, no. 8: 946–951. https://doi.org/10.1038/ejhg.2017.86.
Yelagandula, R., K. Stecher, M. Novatchkova, et al. 2023. “ZFP462 Safeguards Neural Lineage Specification by Targeting G9A/GLP‐Mediated Heterochromatin to Silence Enhancers.” Nature Cell Biology 25, no. 1: 42–55. https://doi.org/10.1038/s41556‐022‐01051‐2.
Zhao, S., C. Miao, X. Wang, Y. Lu, H. Liu, and X. Zhang. 2022. “A Nonsense Variant of ZNF462 Gene Associated With Weiss‐Kruszka Syndrome‐Like Manifestations: A Case Study and Literature Review.” Frontiers in Genetics 13: 781832. https://doi.org/10.3389/fgene.2022.781832.
Zhou, Y., J. Liu, S. Wu, W. Li, and Y. Zheng. 2022. “Case Report: A Heterozygous Mutation in ZNF462 Leads to Growth Hormone Deficiency.” Frontiers in Genetics 13: 1015021. https://doi.org/10.3389/fgene.2022.1015021.

Auteurs

Anna Hau (A)

Hunter Genetics, Hunter New England Health Service, Newcastle, Australia.

Anne Baxter (A)

Hunter Genetics, Hunter New England Health Service, Newcastle, Australia.

Kate Chandler (K)

Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Saint Mary's Hospital, Manchester, UK.

Andrew Fennell (A)

Monash Genetics, Monash Health, Melbourne, Australia.
Department of Paediatrics, Monash University, Melbourne, Australia.

Tzung-Chien Hsieh (TC)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Peter M Krawitz (PM)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Jason Pinner (J)

Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.

Himanshu Goel (H)

Hunter Genetics, Hunter New England Health Service, Newcastle, Australia.
School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.

Classifications MeSH